On the public citation graph

G3bp1 is Involved in Tamoxifen-Resistance of Breast Cancer May Via Pi3k/Akt/Mtor Signaling Axis

0 signed · 16 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/cam4.2579openalex-extracted
Elevated expression of G3BP1 associates with YB1 and p‐AKT and predicts poor prognosis in nonsmall cell lung cancer patients after surgical resection
inferredcites →https://doi.org/10.1002/jcp.28648openalex-extracted
Loss of G3BP1 suppresses proliferation, migration, and invasion of esophageal cancer cells via Wnt/β‐catenin and PI3K/AKT signaling pathways
inferredcites →https://doi.org/10.1007/s10549-018-5023-4openalex-extracted
Resistance to endocrine therapy in breast cancer: molecular mechanisms and future goals
inferredcites →https://doi.org/10.1007/s40265-020-01394-wopenalex-extracted
Targeting the PI3K/AKT/mTOR Pathway in Hormone-Positive Breast Cancer
inferredcites →https://doi.org/10.1016/j.cell.2020.12.024openalex-extracted
G3BPs tether the TSC complex to lysosomes and suppress mTORC1 signaling
inferredcites →https://doi.org/10.1016/j.ctrv.2013.03.009openalex-extracted
Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer
inferredcites →https://doi.org/10.1016/j.mce.2015.09.035openalex-extracted
Endocrine resistance in breast cancer – An overview and update
inferredcites →https://doi.org/10.1016/s0140-6736(05)66544-0openalex-extracted
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
inferredcites →https://doi.org/10.1038/s41419-018-0504-2openalex-extracted
G3BP1 promotes tumor progression and metastasis through IL-6/G3BP1/STAT3 signaling axis in renal cell carcinomas
inferredcites →https://doi.org/10.1038/s41467-021-27093-yopenalex-extracted
HER2 + breast cancers evade anti-HER2 therapy via a switch in driver pathway
inferredcites →https://doi.org/10.1093/jnci/dji372openalex-extracted
Tamoxifen for the Prevention of Breast Cancer: Current Status of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
inferredcites →https://doi.org/10.1111/his.12695openalex-extracted
Overexpression of Ras‐GTPase‐activating protein SH3 domain‐binding protein 1 correlates with poor prognosis in gastric cancer patients
inferredcites →https://doi.org/10.1111/j.1349-7006.2012.02361.xopenalex-extracted
GAP 161 targets and downregulates G 3 BP to suppress cell growth and potentiate cisplaitin‐mediated cytotoxicity to colon carcinoma HCT 116 cells
inferredcites →https://doi.org/10.1128/mcb.16.6.2561openalex-extracted
A Ras-GTPase-Activating Protein SH3-Domain-Binding Protein
inferredcites →https://doi.org/10.1158/1940-6207.capr-09-0185openalex-extracted
Epigallocatechin Gallate Suppresses Lung Cancer Cell Growth through Ras–GTPase-Activating Protein SH3 Domain-Binding Protein 1
inferredcites →https://doi.org/10.3322/caac.21654openalex-extracted
Cancer Statistics, 2021
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.